Cleared Traditional

K962577 - ARROWGARD BLUE QUAD-LUMEN CENTRAL VENOU...

K962577 is an FDA 510(k) clearance for ARROWGARD BLUE QUAD-LUMEN CENTRAL VENOU..., manufactured by Arrow Intl., Inc.. The device is a Class 2 General Hospital device with product code FOZ cleared through the Traditional 510(k) pathway after a 416-day FDA review.

K962577 · Arrow Intl., Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1997
Decision
416d
Days
Class 2
Risk

K962577 is an FDA 510(k) clearance for the ARROWGARD BLUE QUAD-LUMEN CENTRAL VENOUS CATHETER. Classified as Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (product code FOZ), Class II - Special Controls.

Submitted by Arrow Intl., Inc. (Reading, US). The FDA issued a Cleared decision on August 21, 1997 after a review of 416 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5200 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Arrow Intl., Inc. devices

FDA 510(k) Submission Details - K962577

510(k) Number K962577 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 1996
Decision Date August 21, 1997
Days to Decision 416 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
287d slower than avg
Panel avg: 129d · This submission: 416d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FOZ Device Classification - Class 2, Special Controls

Product Code FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 299
Devices cleared under the same product code (FOZ) and FDA review panel - the closest regulatory comparables to K962577.
FIRST MIDCATH CATHETER
K972264 · Becton Dickinson Infusion Therapy Systems, Inc. · Sep 1997
FIRST MIDCATH CATHETER
K972254 · Becton Dickinson Infusion Therapy Systems, Inc. · Sep 1997
VYGON UMBILICAL CATHETHER INSERTION TRAY
K963196 · Vygon Corp. · Sep 1997
V-CATH
K964966 · Hdc Corp. · Mar 1997
CVP POLYURETHANE CATHETER
K961552 · Abbott Laboratories · Feb 1997
FIRST MIDCATH CATHETER KIT
K964048 · Becton Dickinson Vascular Access, Inc. · Jan 1997